[1]
C. Ucciferri, A. Occhionero, J. Vecchiet, and K. Falasca, “Cardiac toxicity associated with HCV direct antiviral agents: Heart in HCV DAAs therapy”, Mediterr J Hematol Infect Dis, vol. 10, no. 1, p. e2018069, Oct. 2018.